Mascoma Corporation Adds Jim Schumacher as Vice President, Business Development

Mascoma Corporation

Mascoma Corporation Adds Jim Schumacher as Vice President, Business Development

August 2, 2007

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Mascoma Corporation, a leader in low-carbon cellulosic biomass-to-ethanol production through advanced biotechnology, today announced that Jim Schumacher has joined the company as Vice President, Business Development. In this role, Mr. Schumacher will lead business development activities and negotiations for domestic and foreign opportunities. He will also oversee key strategic partnerships and merger and acquisition activities for the firm.

“In our active growth mode, we must identify, develop, and close on opportunities rapidly. Jim’s combination of dealmaking ability and transaction-oriented legal expertise make him a strong addition to our firm,” said Mascoma CEO Bruce A. Jamerson.

“I was attracted to Mascoma by the company’s outstanding management team and innovative, environmentally friendly approach to solving our country’s energy and climate change challenges,” said Mr. Schumacher. “I look forward to helping Mascoma grow rapidly and develop successful relationships with our domestic and international partners.”

Mr. Schumacher was most recently founder and President of Schumacher Partners, a real-estate development and investment company. Prior to that, he was a Partner at DLA Piper (formerly Gray Cary) in Palo Alto, California, focusing on capital raising, mergers and acquisitions, and general legal and business advice for technology companies. He earned a J.D. at Indiana University and a B.A. at Purdue University.

About Mascoma Corporation

Mascoma Corporation is a low-carbon cellulosic biomass-to-ethanol company headquartered in Cambridge, Massachusetts, with a research and development laboratory in Lebanon, New Hampshire. Mascoma is developing advanced technologies in its own laboratory, with Professor Lee Lynd at Dartmouth College’s Thayer School of Engineering, by licensing “best in class” microorganisms and enzymes, and with other sponsored research around the world. It is also developing demonstration and commercial scale production facilities in several locations. For more information, visit


Makovsky + Company
Priscilla Li, 212-508-9659